Cover Image
市場調查報告書

血腫:全球臨床實驗檢討

Hematoma Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 312395
出版日期 內容資訊 英文 62 Pages
訂單完成後即時交付
價格
Back to Top
血腫:全球臨床實驗檢討 Hematoma Global Clinical Trials Review, H2, 2014
出版日期: 2014年09月10日 內容資訊: 英文 62 Pages
簡介

本報告提供血腫相關臨床研究的最新趨勢分析,提供您疾病·治療方法概要,及G7各國的臨床實驗狀況,地區、階段、phase別進行狀況,彙整有潛力的贊助商,各企業及研究機關的研究進行狀況,有潛力的藥劑比較等資訊。

簡介

  • 血腫
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區的主要國家的臨床實驗數量
    • 歐洲的主要5個國家的臨床實驗數量
    • 北美的主要國家的臨床實驗數量
    • 中東·非洲的主要國家的臨床實驗數量
    • 中南美的主要國家的臨床實驗數量

G7各國臨床實驗數量:心血管疾病臨床實驗上,血腫所佔的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:心血管疾病臨床實驗上,血腫所佔的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗上,目標的達成情形

未完成的臨床實驗數量 血腫

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

參與血腫治療藥臨床實驗的主要企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • URSAPHARM Arzneimittel GmbH
    • Minapharm Pharmaceuticals & Chemical Industries
    • Baxter International Inc.
  • 有代表性的研究機關·醫院臨床實驗概要
    • University of Ottawa Heart Institute
    • Centre Hospitalier Universitaire de Saint Etienne
    • Islamic Azad University of Tabriz
    • Hvidovre University Hospital
    • Odense University Hospital
    • Medical University of Vienna
    • All India Institute of Medical Sciences
    • Hadassah Medical Organization
    • University Hospital, Grenoble
    • Washington University School of Medicine

5個有代表性的臨床實驗簡介

附錄

目錄

GlobalData's clinical trial report, "Hematoma Global Clinical Trials Review, H2, 2014" provides data on the Hematoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hematoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hematoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Hematoma
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Hematoma to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Hematoma to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Hematoma
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Hematoma Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • URSAPHARM Arzneimittel GmbH
      • Clinical Trial Overview of URSAPHARM Arzneimittel GmbH
      • Minapharm Pharmaceuticals & Chemical Industries
      • Clinical Trial Overview of Minapharm Pharmaceuticals & Chemical Industries
      • Baxter International Inc.
      • Clinical Trial Overview of Baxter International Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • University of Ottawa Heart Institute
      • Clinical Trial Overview of University of Ottawa Heart Institute
      • Centre Hospitalier Universitaire de Saint Etienne
      • Clinical Trial Overview of Centre Hospitalier Universitaire de Saint Etienne
      • Islamic Azad University of Tabriz
      • Clinical Trial Overview of Islamic Azad University of Tabriz
      • Hvidovre University Hospital
      • Clinical Trial Overview of Hvidovre University Hospital
      • Odense University Hospital
      • Clinical Trial Overview of Odense University Hospital
      • Medical University of Vienna
      • Clinical Trial Overview of Medical University of Vienna
      • All India Institute of Medical Sciences
      • Clinical Trial Overview of All India Institute of Medical Sciences
      • Hadassah Medical Organization
      • Clinical Trial Overview of Hadassah Medical Organization
      • University Hospital, Grenoble
      • Clinical Trial Overview of University Hospital, Grenoble
      • Washington University School of Medicine
      • Clinical Trial Overview of Washington University School of Medicine
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Hematoma Therapeutics, Global, Clinical Trials by Region, 2014*
  • Hematoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Hematoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Hematoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Hematoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Hematoma Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Hematoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Hematoma Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Hematoma to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Hematoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Hematoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Hematoma to Cardiovascular Clinical Trials, E7 Countries (%), 2014*
  • Hematoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Hematoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Hematoma Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Hematoma Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Hematoma Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Hematoma Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Hematoma Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Hematoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Hematoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Hematoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Hematoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Hematoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Hematoma Therapeutics Clinical Trials Market, Global, Clinical Trials by URSAPHARM Arzneimittel GmbH, 2014*
  • Hematoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Minapharm Pharmaceuticals & Chemical Industries, 2014*
  • Hematoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Baxter International Inc., 2014*
  • Hematoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Ottawa Heart Institute, 2014*
  • Hematoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire de Saint Etienne, 2014*
  • Hematoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Islamic Azad University of Tabriz, 2014*
  • Hematoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Hvidovre University Hospital, 2014*
  • Hematoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Odense University Hospital, 2014*
  • Hematoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2014*
  • Hematoma Therapeutics Clinical Trials Market, Global, Clinical Trials by All India Institute of Medical Sciences, 2014*
  • Hematoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical Organization, 2014*
  • Hematoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Grenoble, 2014*
  • Hematoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2014*

List of Figures

  • Hematoma Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Hematoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Hematoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Hematoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014*
  • Hematoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Hematoma Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Hematoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Proportion of Hematoma to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Hematoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Hematoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Hematoma to Cardiovascular Clinical Trials, E7 Countries (%), 2014*
  • Hematoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Hematoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Hematoma Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Hematoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Hematoma Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Hematoma Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Hematoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Hematoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Hematoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Hematoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Hematoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top